1. Home
  2. SVCO vs GBIO Comparison

SVCO vs GBIO Comparison

Compare SVCO & GBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SVCO
  • GBIO
  • Stock Information
  • Founded
  • SVCO 1984
  • GBIO 2016
  • Country
  • SVCO United States
  • GBIO United States
  • Employees
  • SVCO N/A
  • GBIO N/A
  • Industry
  • SVCO
  • GBIO Biotechnology: Pharmaceutical Preparations
  • Sector
  • SVCO
  • GBIO Health Care
  • Exchange
  • SVCO NYSE
  • GBIO Nasdaq
  • Market Cap
  • SVCO 198.0M
  • GBIO 165.5M
  • IPO Year
  • SVCO 2024
  • GBIO 2020
  • Fundamental
  • Price
  • SVCO $7.54
  • GBIO $1.32
  • Analyst Decision
  • SVCO Strong Buy
  • GBIO Strong Buy
  • Analyst Count
  • SVCO 6
  • GBIO 2
  • Target Price
  • SVCO $20.83
  • GBIO $7.50
  • AVG Volume (30 Days)
  • SVCO 319.7K
  • GBIO 161.6K
  • Earning Date
  • SVCO 11-12-2024
  • GBIO 11-06-2024
  • Dividend Yield
  • SVCO N/A
  • GBIO N/A
  • EPS Growth
  • SVCO N/A
  • GBIO N/A
  • EPS
  • SVCO N/A
  • GBIO N/A
  • Revenue
  • SVCO $54,307,000.00
  • GBIO $18,582,000.00
  • Revenue This Year
  • SVCO $15.65
  • GBIO $188.06
  • Revenue Next Year
  • SVCO $17.06
  • GBIO N/A
  • P/E Ratio
  • SVCO N/A
  • GBIO N/A
  • Revenue Growth
  • SVCO 5.33
  • GBIO 514.08
  • 52 Week Low
  • SVCO $6.14
  • GBIO $1.10
  • 52 Week High
  • SVCO $21.59
  • GBIO $4.65
  • Technical
  • Relative Strength Index (RSI)
  • SVCO N/A
  • GBIO 23.42
  • Support Level
  • SVCO N/A
  • GBIO $2.14
  • Resistance Level
  • SVCO N/A
  • GBIO $2.57
  • Average True Range (ATR)
  • SVCO 0.00
  • GBIO 0.21
  • MACD
  • SVCO 0.00
  • GBIO -0.09
  • Stochastic Oscillator
  • SVCO 0.00
  • GBIO 6.02

About SVCO SILVACO GROUP INC

Silvaco Group Inc is a provider of technology computer aided design ("TCAD") software, electronic data automation ("EDA") software and semiconductor intellectual property ("SIP"). TCAD, EDA and SIP solutions enable semiconductor and photonics companies to increase productivity, accelerate their products' time-to-market and reduce their development and manufacturing costs. It is developing the "technology behind the chip" and providing solutions that span from atoms to systems, starting with providing software for the atomic level simulation of semiconductor and photonics material for devices, to providing software and SIP for the design and analysis of circuits and system level solutions.

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company that is focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable highly differentiated therapeutic applications. Its first platform is a potent, highly selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for highly selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

Share on Social Networks: